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Tissue Plasminogen Activator and Plasminogen Activator 
Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
To investigate the effects of reactive oxygen species (ROS) on tissue plasminogen activator 
(tPA) and plasminogen activator inhibitor-1 (PAI-1) plasma levels, and their possible 
implications on clinical outcome, we measured tPA and PAI-1 levels in 101 patients with 
acute paraquat (PQ) intoxication. The control group consisted of patients who ingested 
non-PQ pesticides during the same period. tPA and PAI-1 levels were higher in the PQ 
group than in the controls. PQ levels were significantly correlated with ingested amount, 
timelag to hospital, tPA level, and hospitalization duration. tPA levels were correlated with 
PAI-1, fibrin degradation product (FDP), and D-dimer. D-dimer levels were lower in the PQ 
group than in the controls. Univariate analysis indicated the following significant 
determinants of death: age, ingested amount, PQ level, timelag to hospital, serum 
creatinine, lipase, pH, pCO2, HCO3
-, WBC, FDP, PAI-1, and tPA. However, multivariate 
analysis indicated that only PQ level was significant independent factor predicting death. 
In conclusion, tPA and PAI-1 levels were higher, while D-dimer levels were lower in the PQ 
group than in the controls, implying that ROS stimulate tPA and PAI-1, but PAI-1 activity 
overrides tPA activity in this setting. Decreased fibrinolytic activity appears to be one of the 
clinical characteristics of acute PQ intoxication.
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INTRODUCTION 
Tissue plasminogen activator (tPA) is a serine protease expressed 
by endothelial cells of blood vessels that catalyzes the conver-
sion of plasminogen to plasmin (1). In addition to its role in the 
fibrinolysis system, tPA is implicated in tissue proliferation, cel-
lular adhesion, and the activation of growth factors and matrix 
metalloproteinases (2). Insight into the regulation of the syn-
thesis and release of tPA has extended markedly over the last 2 
decades, including the characterization of the intracellular sig-
naling pathways, promoter elements, and transcription factors 
involved in the transcriptional regulation of tPA (3, 4). 
  The tPA gene is located on chromosome 8 (5). Evidence from 
experimental studies indicates that reactive oxygen species (ROS) 
can inhibit tPA mRNA expression and synthesis, and impair the 
release of tPA from cultured human endothelium (6, 7). Further-
more, oxidants may alter the structural characteristics of tPA, 
which in turn may adversely affect endothelial fibrinolytic ac-
tivity (8). However, these observations were derived from in vi-
tro experiments or from experimental animal models. Van Guil-
der et al. observed that the antioxidant vitamin C increased the 
capacity of the endothelium to release tPA in overweight/obese 
adults (9). They concluded that ROS inhibit tPA production; how-
ever, it is not clear whether high levels of ROS suppress plasma 
tPA levels, leading to thrombosis in humans.
  Plasminogen activator inhibitor-1 (PAI-1) is the principal in-
hibitor of tPA (10). It is mainly produced by the cells lining blood 
vessels, but it is also secreted by other tissue types, e.g., adipose 
tissue. The PAI-1 gene is located on chromosome 7 (7q21.3-q22) 
(11). There is little information regarding the effects of ROS on 
the production of PAI-1 (3, 12).
  Paraquat (PQ, 1,1´-dimethyl-4,4´-bipyridinium dichloride) is 
one of the most commonly used herbicides in the world (13-15). 
In human, intentional or accidental ingestion of PQ is consid-
ered to be uniformly fatal, resulting in death from multi-organ 
failure and cardiogenic shock within few days (16). After inges-
tion of small quantities, PQ is specially taken up into and accu-
mulates in the lung. Subsequent redox cycling and free radical 
generation triggers a neutrophil-mediated inflammatory re-
sponse in the lungs, which initiates an irreversible fibrotic pro-
cess that kills the majority of patients within several weeks (17). 
Considering that PQ is the most frequently used chemical to 
produce ROS in vitro experiments, acute PQ intoxication could 
be a human model to study specific clinical conditions related 
to ROS.
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of tPA and PAI-1 in patients with acute PQ intoxication, focus-
ing on the relationship between these parameters and the clini-
cal features of PQ intoxication.
MATERIALS AND METHODS
Soonchunhyang Cheonan Hospital’s Investigational Review 
Board approved this study, and all participants gave written in-
formed consent. We enrolled 101 patients (58 males and 43 fe-
males, aged 49.1 ± 16.0 yr) with acute PQ intoxication in this 
study. All of the patients ingested concentrated PQ (22%-23% 
per volume) while committing suicide and were admitted to 
the Institute of Pesticide Poisoning, Soonchunhyang University 
Cheonan Hospital, from September 2009 to March 2010. The 
amount ingested was estimated from the number of swallows, 
where 1 mouthful was considered as 20 mL. 
  For the control group, we enrolled 30 patients (14 males and 
16 females, aged 53.5 ± 16.6 yr) with acute non-PQ pesticide in-
toxication. The control group also ingested pesticides while com-
mitting suicide and were admitted to the same hospital during 
the same period. The frequency of ingested pesticides in the 
control group was as follows: organophosphate, 9 (30%); glypho-
sate, 6 (20%); glufosinate, 5 (16.7%); pyrethroid, 3 (10%); and 
others, 7 (23.3%). The demographic and basal laboratory find-
ings for both groups of patients are summarized in Table 1.
  Upon admission, the patients received the following standard-
ized medical emergency procedures. Briefly, a gastric lavage 
was performed on all subjects who presented to the emergency 
room (ER) within 2 hr of PQ ingestion. For those whose intoxica-
tion occurred within 12 hr before presenting to the ER, 100 g of 
Fuller’s earth in 200 mL of 20% mannitol was administered. He-
moperfusion was initiated early and continued for 4-6 hr accord-
ing to the result of the urine dithionite test. Glutathione (50 mg/
kg/24 hr) was administered intravenously for 3 additional days 
as an ROS scavenger. For the control group, early hemoperfu-
sion was performed on the first day of hospitalization in the same 
manner as the PQ group and conservative therapy was followed. 
For patients with organophosphate intoxication, atropine and 
pralidoxime (PAM) were administered.
  Blood samples were collected in the ER for baseline laborato-
ry findings. The PQ levels were measured by the HPLC method.
  There are various ways to estimate the tPA mediated fibrino-
lytic activity, such as measurement of tPA with catalytic activity 
and/or quantification of tPA antigen, as a free form or complex 
form of tPA-PAI-1. In this study, we measured tPA and PAI-1 an-
tigen to observe the effect of ROS on the production and/or re-
lease of tPA and PAI-1 each. Of course, tPA and PAI-1 antigen 
are not consistent with the activity of tPA and PAI-1. In order to 
compensate for the defect, we measure fibrin degradation prod-
uct (FDP) and D-dimer, which are always the end-products of 
fibrinolysis. Besides, they represent the pre-existence of throm-
bus.
  To quantify tPA and PAI-1 levels, plasma samples were col-
lected 3 times: the first sample was collected in the ER and the 
other 2 samples were taken on consecutive days at 24 hr inter-
vals. tPA (Asserachrom
® tPA kit; Diagnostica Stago, Asnières-
Sur-Seine, France) and PAI-1 (Asserachrom
® PAI-1 kit; Diagnos-
tica Stago) antigen levels were measured using commercially 
available assay kits. tPA and PAI-1 levels were presented as the 
mean of these 3 measurements.
Statistical analysis 
Continuous variables are presented as the mean ± standard de-
viation and categorical variables as frequency (in percent). The 
differences between the PQ and control groups were compared 
using Student’s t-test for continuous variables and by the chi-
squared-test or Fisher’s exact test for categorical variables. The 
relationship between variables was analyzed using bivariate 
correlation analysis. Univariate binary logistic regression analy-
sis was used to verify the clinical implications of the fibrinolytic 
markers, e.g., tPA and PAI-1. Multivariate logistic regression anal-
ysis was used to identify significant determinants of death after 
PQ intoxication. The results of the logistic regression analyses 
Table 1. The demographic and laboratory findings for the paraquat and control into­
xication groups 
Parameters Control group  
(n = 30)
Paraquat group  
(n = 101)
P 
value
Sex (female/male), No. 16/14 43/58 0.298
Death, No. (%) 2 (6.7%) 56 (55.4%) < 0.001
Age (yr)     53.5 ± 16.6     49.1 ± 16.0  0.205
Time lag to hospital (hr)     11.9 ± 20.2        13 ± 17.6 0.798
Hospitalization duration (days)     12.2 ± 13.8     7.4 ± 6.1 0.008
Laboratory findings
   AST (IU/L)     35 ± 17      43 ± 96  0.439
   ALT (IU/L)     25 ± 15      28 ± 40  0.550
   Urea nitrogen (mg/dL)   16.8 ± 9.6      16.7 ± 12.5  0.987
   Creatinine (mg/dL)     0.9 ± 0.5      1.2 ± 1.1  0.048
   Sodium (mEq/L) 143 ± 5  141 ± 7  0.042
   Potassium (mEq/L)     4.0 ± 0.8      3.5 ± 0.7  0.003
   Amylase (IU/L)     296 ± 306      252 ± 281  0.487
   Lipase (U/L)       98 ± 192        91 ± 242  0.863
   pH     7.35 ± 0.14      7.39 ± 0.08  0.039
   pCO2 (mmHg)     36.1 ± 10.7    30.4 ± 7.0  0.001
   pO2 (mmHg)   100.8 ± 75.8      95.7 ± 19.2  0.541
   HCO3 (mEq/L)   19.6 ± 5.4    18.3 ± 5.2  0.225
   WBC (× 10
3/µL)   14.7 ± 8.6   15.2 ± 7.5  0.769
   Hemoglobin (g/dL)   14.2 ± 2.1  14.1 ± 2.1  0.936
   Hematocrit (%) 42.5 ± 5.6    42.0 ± 5.7  0.712
   Platelet (× 10
3/µL)   237 ± 72    237 ± 79  0.968
   D­dimer (µg/mL)     2.1 ± 1.1      1.2 ± 1.1  0.001
   FDP (µg/mL)     7.4 ± 3.3      6.3 ± 3.9  0.117
   PAI­1 (ng/mL)     51.3 ± 23.0      69.9 ± 25.0  0.001
   tPA (ng/mL)     18.0 ± 12.7      24.8 ± 15.2  0.038
AST, Aspartate transaminase; ALT, Alanine transaminase; WBC, white blood cell 
count; FDP, fibrin degradation product; PAI­1, plasminogen activator inhibitor­1; tPA, 
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were reported as odds ratio with 95% confidence intervals (CI). 
Statistical analyses were performed using SPSS software (ver-
sion 14.0; SPSS Inc., Chicago, IL, USA). All P values below 0.05 
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Fig. 1. Comparison of the tPA and PAI­1 levels between the control and PQ intoxication 
groups. Note that tPA and PAI­1 levels are significantly higher in the PQ group than in 
the control group. 
were considered statistically significant.
Ethics statement
The protocol and standardized clinical format was approved by 
the Soonchunhyang Cheonan Hospital’s Investigational Review 
Board (2010-91). The informed consent was exempted.
RESULTS
Comparison of tPA, PAI-1, FDP, and D-dimer levels 
between the PQ and control groups
tPA (24.8 ± 15.2 vs 18.0 ± 12.7 ng/mL, respectively, P = 0.038) 
and PAI-1 (69.9 ± 25.0 vs 51.3 ± 23.0 ng/mL, respectively, P = 
0.001) levels were significantly higher in the PQ group than in 
the control group (Fig. 1). D-dimer levels were significantly low-
er in the PQ group than in the control group (1.2 ± 1.1 vs 2.1 ± 
1.1 μg/mL, respectively, P = 0.001) (Fig. 2). However, there were 
no significant differences in the levels of FDP between the con-
trol and PQ groups (7.4 ± 3.3 vs 6.3 ± 3.9 μg/mL, respectively, P = 
(
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Fig. 2. Comparison of the levels of D­dimer and fibvin degradation product (FDP) 
between the control and PQ intoxication groups. Note that the D­dimer levels are 
significantly lower in the PQ group than in the control group.
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Fig. 3. Relationship between PQ levels and the levels of tPA and PAI­1 in PQ­intoxi­
cated patients. PQ­intoxicated patients were divided into 2 subgroups according to 
their PQ level: ≥ 10 µg/mL vs < 10 µg/mL.
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Fig. 4. Relationship between the amount of PQ ingested and the levels of tPA (A) and PAI­1 (B) in PQ­intoxicated patients. Note that there is a positive correlation between the 
amount of PQ ingested and the levels of tPA and PAI­1.
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0.117). 
Relationship between tPA and PAI-1 levels and the PQ 
level and amount of PQ ingested in PQ-intoxicated 
patients
Patients with PQ intoxication were divided into 2 subgroups ac-
cording to their PQ level: ≥ 10 μg/mL vs < 10 μg/mL. Patients 
whose PQ levels were over 10 μg/mL had significantly higher 
levels of tPA than those below 10 μg/mL (36.3 ± 13.0 vs 18.3 ± 
11.7 ng/mL, respectively, P < 0.001) (Fig. 3). In addition, bivari-
ate correlation analysis revealed a significant correlation be-
tween PQ levels and the amount of PQ ingested (r = 0.281, P = 
0.005), the time interval between PQ ingestion and hospital ad-
mission (r = -0.286, P = 0.004), the level of tPA (r = 0.417, P = 0.001) 
and hospitalization duration (r = -0.419, P < 0.001).
  The amount of PQ ingested demonstrated a positive relation-
ship with the levels of tPA (r = 0.579, P < 0.001) and PAI-1 (r = 
0.428, P < 0.001) (Fig. 4); similarly, the levels of tPA were signifi-
cantly correlated with the levels of PAI-1 (r = 0.621, P < 0.001), 
FDP (r = 0.479, P < 0.001), and D-dimer (r = 0.312, P = 0.014).
Comparison of tPA, PAI-1, and PQ levels, the amount of 
PQ ingested, and blood chemistry between the deceased 
and survived groups for PQ intoxication
Fifty-six (55.4%) patients died in the PQ group; while 2 (6.7%) 
patients died in the control group. The demographic and labo-
ratory findings for the survivors and non-survivors are summa-
rized in Table 2. Briefly, the deceased patients were older, in-
gested larger amounts of PQ, arrived at hospital later, and had 
higher levels of PQ, tPA, and PAI-1 than those who survived.
  Univariate binary logistic regression analysis of the PQ group 
indicated that the following factors were significant determi-
nants of death: age, amount of PQ ingested, PQ levels, time lag 
between PQ ingestion and admission, hospitalization duration, 
serum creatinine, potassium, lipase, pH, pCO2, HCO3
-, white 
blood cell count (WBC), FDP, PAI-1, and tPA levels (Table 3). 
However, multivariate binary logistic regression analysis indi-
Table 2. Demographic and laboratory findings between the survived and deceased 
groups of paraquat­intoxicated patients
Parameters Survived group  
(n = 43)
Deceased group  
(n = 56) P value
Sex (female/male), No. 21/22 20/36 0.189
Age (yr) 43 ± 15.3 53.6 ± 15.5 0.001
Amount of ingestion (mL) 21.9 ± 23.9 89.3 ± 90 < 0.001
PQ level (µg/mL) 0.4 ± 0.6 18.8 ± 20.5 < 0.001
Time lag to hospital (hr) 18 ± 21.4 8.4 ± 11.6 0.005
Hospitalization duration (days) 11.8 ± 6.0 4.3 ± 3.6 < 0.001
Laboratory findings
   AST (IU/L) 29 ± 17 53 ± 127 0.160
   ALT (IU/L) 23 ± 20 31 ± 51 0.293
   Urea nitrogen (mg/dL) 15.6 ± 11.4 16.9 ± 11.3 0.570
   Creatinine (mg/dL) 0.8 ± 0.6 1.4 ± 1.2 0.005
   Sodium (mEq/L) 140 ± 6 141 ± 7 0.559
   Potassium (mEq/L) 3.8 ± 0.5 3.2 ± 0.7 < 0.001
   Amylase (IU/L) 208 ± 182 269 ± 304 0.221
    Lipase (U/L) 29 ± 12 127 ± 303 0.037
   pH 7.42 ± 0.04 7.36 ± 0.09 < 0.001
   pCO2 (mmHg) 34.2 ± 4.8 27.4 ± 7.1 < 0.001
   pO2 (mmHg) 93.4 ± 18.8 97.7 ± 19.6 0.276
   HCO3 (mEq/L) 21.9 ± 2.9 15.5 ± 4.9 < 0.001
   WBC (× 10
3/µL) 10.6 ± 4.0 18.8 ± 7.7 < 0.001
   Hemoglobin (g/dL) 14.1 ± 2 14.1 ± 2.2 0.969
   Hematocrit (%) 42 ± 5.5 42.1 ± 6 0.893
   Platelet (× 10
3/µL) 239 ± 77 240 ± 79 0.949
   D­dimer (µg/mL) 1.4 ± 3.8 2.9 ± 10.6 0.339
   FDP (µg/mL) 4.6 ± 3 7.6 ± 4.1 < 0.001
   PAI­1 (ng/mL) 54.5 ± 20.8 82.4 ± 19.2 < 0.001
   tPA (ng/mL) 12.6 ± 6.4 33.3 ± 13.7 < 0.001
AST, Aspartate transaminase; ALT, Alanine transaminase; WBC, white blood cell 
count; FDP, fibrin degradation product; PAI­1, plasminogen activator inhibitor­1; tPA, 
tissue plasminogen activator.
Table 3. Univariate binary logistic regression analysis to identify significant determi­
nants of death in paraquat­intoxicated patients
Variables P value OR 95% CI
Age (yr) 0.002 1.046 1.017 1.077
Amount of ingestion (mL) < 0.001 1.040 1.020 1.060
PQ level (μg/mL) < 0.001 5.270 2.384 11.649
Time lag to hospital (hr) 0.014 0.963 0.934 0.992
Hospitalization duration (days) < 0.001 0.677 0.582 0.787
Creatinine (mg/dL) 0.012 3.462 1.311 9.138
Potassium (mEq/L) < 0.001 0.236 0.110 0.506
Lipase (U/L) 0.005 1.050 1.015 1.087
pH < 0.001 1.9 × 10
­6 1.4 × 10
­9 0.003
pCO2 (mmHg) < 0.001 0.827 0.755 0.905
HCO3 (mEq/L) < 0.001 0.642 0.533 0.774
WBC (× 10
3/µL) < 0.001 1.0003 1.0001 1.0004
FDP (µg/mL) < 0.001 1.266 1.110 1.443
PAI­1 (ng/mL) < 0.001 1.064 1.032 1.097
tPA (ng/mL) < 0.001 1.212 1.094 1.344
WBC, white blood cell count; FDP, fibrin degradation product; PAI­1, plasminogen 
activator inhibitor­1; tPA, tissue plasminogen activator.
Table 4. Multivariate binary logistic regression analysis to verify significant determi­
nants of death in paraquat­intoxicated patients. Values of tPA and PAI­1 were adjusted 
by age, sex, time interval between PQ ingestion and hospital arrival, PQ levels, amount 
of PQ ingested and serum creatinine levels
Variables P value OR 95% CI
Amount of ingestion (mL) 0.456 1.037 0.943 1.140
PQ level (µg/mL) 0.014 16.052 1.747 147.520
Potassium (mEq/L) 0.850 1.362 0.055 33.742
Lipase (U/L) 0.859 1.002 0.980 1.025
pH 0.307 4.7 × 10
11 < 0.001 1.2 × 10
34
pCO2 (mmHg) 0.541 0.894 0.623 1.281
HCO3 (mEq/L) 0.835 1.044 0.693 1.573
WBC (× 10
3/µL) 0.349 1.0003 0.9996 1.001
FDP (µg/mL) 0.835 1.081 0.521 2.242
PAI­1 (ng/mL) 0.997 0.801 < 0.001 8.7 × 10
57
tPA (ng/mL) 0.991 16.827 < 0.001 1.1 × 10
219
WBC, white blood cell count; FDP, fibrin degradation product; PAI­1, plasminogen 
activator inhibitor­1; tPA, tissue plasminogen activator.Seok S-J, et al.  •  tPA and PAI-1 Levels in Paraquat Intoxication
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cated that only PQ levels, from these factors, were a significant 
independent factor predicting death (Table 4).
DISCUSSION
Coagulation and fibrinolysis proceed concomitantly, since a 
thrombus is formed on a damaged vessel wall and leads to the 
release of tPA from the intact endothelium nearby the throm-
bus (18). Consequently, tPA activates the conversion of plas-
minogen to plasmin, inducing the so-called “thrombus-specific 
fibrinolysis (19)”. Venous thrombosis has many different etiolo-
gies and occurs when several risk factors are present simultane-
ously (20). Risk factors in patients with acute pesticide intoxica-
tion, in addition to the traditional ones, include prolonged bed 
rest (21), placement of central venous catheters (22), and he-
moperfusion (23). This is the reason why we recruited a control 
group consisting of patients with non-PQ pesticide intoxication 
who underwent similar treatment modalities as the PQ group, 
including bed rest, a central venous catheter for the extracorpo-
real elimination of poisons, and/or the intravenous administra-
tion of a large volume of fluid. 
  Contrary to the previous reports (6, 7, 9), we observed signifi-
cantly higher levels of tPA and PAI-1 in the PQ group than in the 
control group (Fig. 1). Furthermore, the levels of tPA and PAI-1 
were significantly higher in patients whose PQ levels were high-
er than 10 μg/mL (Fig. 3). We cannot explain this discrepancy, 
but in the previous reports (6, 7), the results were described from 
not in vivo but in vitro experiments. In another previous study 
(9), they reported decreased levels of tPA after the injection of 
vitamin C in human subjects. With this result, they concluded 
that ROS may inhibit tPA production. However, their theory is 
open to criticism because the function of vitamin C is compli-
cated in ROS formation, not scavenging ROS but stimulate ROS 
production in some situation. 
  In our results, there was a significant correlation between the 
levels of tPA and/or PAI-1 with the amount of PQ ingested (Fig. 4). 
A B
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Fig. 5. Pulmonary artery computerized tomography angiogram from a PQ­intoxicated patient who suffered pulmonary artery thrombosis. A 64­yr­old woman swallowed a 
mouthful of a 24.5% PQ solution. Her plasma PQ level was 0.08 µg/mL at 15 hr after PQ ingestion. On day 9 of admission, the patient complained of right sided chest pain and 
dyspnea. Arterial blood gas analysis indicated: pH, 7.459; PaO2, 46.3 mmHg; and PaCO2, 37.9 mmHg. D­dimer was elevated at 2.9 (0–0.5) µg/mL. A chest X­ray showed an 
increased density along the apex of the right lung. (A) obtained at 9 days after PQ ingestion. Note the thrombus in the pulmonary artery and interlobar pulmonary artery (arrow a, 
b). A subcutaneous injection of low molecular weight heparin was started on the 9th day and warfarin was started on the 10th day. (B) obtained at 20 days after PQ ingestion. 
The thrombus was completely resolved (arrow c, d). The patient made a full recovery from this condition.
a
c
d
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Fig. 6. Low extremity venogram computerized tomography from a PQ­intoxicated patient who suffered deep vein thrombosis in the leg. A 50­yr­old woman swallowed 2 mouth­
fuls of a 24.5% PQ solution. (A) On day 21 after admission, the patient complained of left leg swelling and pain, and a deep vein thrombosis was suspected. D­dimer was elevated 
at 25.6 µg/mL. (B) Deep vein thrombosis was noted in the left deep venous system (arrow a, b). (C, D) Obtained at 63­days after PQ ingestion. The extent of the thrombus was 
significantly reduced (arrow c, d). 
a
c
b
d
The plasma PQ level at a given time is a function of the amount 
ingested and the time lag after ingestion; therefore, the PQ level 
does not represent the severity of intoxication in our study be-
cause the patients arrived at the ER with different time lags after 
ingestion. However, it has been our clinical observation that no 
patients survive with a plasma PQ level > 10 μg/mL during the 
admission period. This observation led us to divide the PQ group 
according to their PQ levels: greater than and lower than 10 μg/
mL. 
  This raises the question of whether these relationships are due 
to PQ itself or an ROS effect generated by PQ. ROS are formed 
primarily in cells; however, direct measurement of ROS forma-
tion in cells is very difficult in the clinical setting. Instead, sever-
al indirect methods have been developed to measure free radi-
cals and their metabolites, e.g., malondialdehyde (MDA; the fi-
nal product of lipid peroxidation) (24) and hydroperoxides 
(ROOH; intermediate products of lipid peroxidation) (25). Re-
cently, we reported that neither cross-sectional nor sequential 
measurements of plasma MDA provided reliable data on ROS 
formation in patients with acute PQ intoxication (24). Given the 
lack of a reliable marker for ROS production, it is difficult to find 
a relationship between ROS levels and other parameters in acute 
PQ intoxication.
  The plasma levels of PQ reach a peak level at 1.5 hr after PQ 
ingestion and decrease so rapidly that its levels are undetect-
able after 24 hr in the majority of patients; therefore, plasma PQ 
levels observed in the ER are not comparable with those from 
the subsequent days. Contrary to the PQ levels, the 3 measure-
ments of tPA and PAI-1 levels taken in this study were compara-
ble in each patient; the mean coefficient of variation was 0.42 ± 
0.22 for tPA (range 0.08-1.02) and 0.39 ± 0.30 for PAI-1 (range 
0.00-1.31). These results suggest that it is not the mere level of 
PQ that affects tPA and PAI-1 levels, but some other factor(s) ac-
tivated or stimulated by PQ; therefore, we consider that ROS gen-
erated by PQ trigger the endothelium to release tPA and PAI-1.
  D-dimer levels were lower in the PQ group than in the con-
trol group (Fig. 2). The presence of D-dimer indicates the pre-
existence of fibrin formation and the concurrent formation of 
plasmin by tPA (26). Coagulation and fibrinolysis are on-going 
physiological processes that account for the presence of D-di-Seok S-J, et al.  •  tPA and PAI-1 Levels in Paraquat Intoxication
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mer. Fibrin formation is the result of the imbalance between 
coagulation and anticoagulation activities in a pathological en-
vironment. Therefore, the possibility exists that some thrombo-
genic factor such as tissue factor could have been activated dur-
ing PQ intoxication; however, changes in coagulation/antico-
agulation activity were not the focus of the current study. In the 
PQ group, tPA and PAI-1 levels were higher, but D-dimer levels 
were lower than in the control group, indicating that, in this set-
ting, PAI-1 activity overrode tPA activity.
  Taken together, these results indicate that thrombosis should 
be a common complication in patients with acute PQ intoxica-
tion, although only 2 of the 101 PQ patients suffered from pul-
monary artery thrombosis or deep vein thrombosis (Figs. 5, 6). 
However, bearing in mind that venous thrombosis is often clini-
cally silent, we believe that there must have been more patients 
with subclinical thrombosis complications in the PQ group.
  In order to verify the clinical implications of the tPA and PAI-1 
levels, we performed univariate and multivariate binary logistic 
regression analyses. Univariate binary logistic regression analy-
sis of the PQ group showed that age, amount of PQ ingested, 
plasma PQ levels, time lag after PQ ingestion, tPA levels, and 
PAI-1 levels were significant determinants of death (Table 3). 
However, multivariate binary logistic regression analysis indi-
cated that only PQ levels were a significant independent factor 
predicting death (Table 4).
  We have few limitations in this study. First, we had better es-
timate the tPA mediated fibrinolytic activity with both tPA anti-
gen and tPA activity. Furthermore, parameters of coagulation, 
such as a tissue factor and its inhibitors would have enhanced 
the significance in the interpretation of the change in both tPA 
and PAI-1 levels. However, in practice, it was hard to obtain blood 
samples frequently in large amount because of their critical con-
dition. The other question posed is the lack of quantitative mea-
surement of ROS.
  As we described in the introduction, it was impossible to mea-
sure ROS directly and only surrogate markers were available in 
clinical practice. Even with these limit, our observations imply 
that ROS stimulate the production of tPA and PAI-1, but PAI-1 
activity overrides tPA activity in this setting. Decreased fibrino-
lytic activity due to increased PAI-1 activity appears to be one of 
the clinical characteristics of acute PQ intoxication.
  In conclusion, the levels of tPA and PAI-1 were higher, but D-
dimer levels were lower in the PQ group than in the control group. 
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Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in 
Patients with Acute Paraquat Intoxication
Su-Jin Seok, Su-Ji Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, and Sae-Yong Hong 
Paraquat (PQ), a toxic herbicide, is highly reactive to oxygen. Here, in PQ-intoxicated patients, we investigated the plasma levels 
of both tissue plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1), and their possible implications on clinical 
outcome. We observed that the levels of both tPA and PAI-1 were higher, while D-dimer levels were significantly lower in the 
patients with PQ-intoxication than in the control group. Univariate analysis indicated the following significant determinants of 
death: age, ingested amount, PQ level, time lag to hospital, serum creatinine, lipase, pH, pCO2, HCO3
-, WBC, FDP, PAI-1, and 
tPA. However, multivariate analysis indicated that only PQ level was significant independent factor predicting death. Our findings 
imply that PQ-induced ROS might stimulate tPA and PAI-1, but PAI-1 activity overrides tPA activity in this setting. Decreased 
fibrinolytic activity appears to be one of the clinical characteristics of acute PQ intoxication.